Clinical research is the study of health and illness in people. It encompasses any research conducted with human participants, from testing a new cancer drug to tracking long-term health patterns across thousands of individuals. Every prescription medication, vaccine, and medical device available today reached the public through clinical research that established its safety and effectiveness in real human bodies.
How Clinical Research Differs From Lab Research
Before any treatment is tested in people, it goes through preclinical research in laboratories and sometimes in animal models. This stage answers basic questions about whether a compound is toxic, how it behaves at the molecular level, and whether it shows enough promise to justify human testing. But lab results can only go so far. A drug that shrinks tumors in a petri dish may do nothing useful inside a living person, or it may cause unexpected side effects that no animal model predicted.
Clinical research picks up where preclinical work leaves off. It’s the bridge between a promising idea and a treatment your doctor can actually prescribe. In the United States, a company must file an Investigational New Drug application with the FDA before testing begins in humans. Once submitted, there’s a mandatory 30-day waiting period before the first participant can be enrolled, giving regulators time to review safety data from the preclinical phase.
Interventional vs. Observational Studies
Clinical research falls into two broad categories. In interventional studies (commonly called clinical trials), researchers actively do something to participants: give them a drug, perform a procedure, or ask them to follow a specific diet. The researcher controls who gets what and measures the results. In observational studies, researchers simply watch and record what happens naturally. They might follow a group of people over decades to see who develops heart disease and look for patterns in diet, exercise, or genetics. The investigator never intervenes or assigns treatments.
Both types generate valuable knowledge, but they answer different questions. Clinical trials can demonstrate that a treatment causes a specific outcome. Observational studies reveal associations and trends that help researchers generate hypotheses or track the safety of treatments already on the market.
The Four Phases of Clinical Trials
Clinical trials follow a structured progression, with each phase designed to answer a different question. A treatment must clear one phase before advancing to the next, and most never make it all the way through.
- Phase I involves 20 to 80 volunteers and focuses purely on safety. Researchers are looking for side effects, figuring out safe dosage ranges, and learning how the body absorbs and processes the treatment. Many Phase I participants are healthy volunteers rather than patients.
- Phase II expands to 100 to 300 people who have the condition the treatment targets. The goal shifts to effectiveness: does this treatment actually work? Researchers also continue monitoring safety.
- Phase III is the large-scale test, enrolling 1,000 to 3,000 participants. These trials confirm effectiveness, compare the new treatment against existing standard treatments, and build the safety profile regulators need to make an approval decision.
- Phase IV happens after a drug is already approved and available to the public. These studies track how the treatment performs in the real world, where patients are more diverse and conditions less controlled than in earlier trials.
The odds of a drug making it from Phase I all the way to FDA approval are low. An analysis of nearly 20,000 clinical trials conducted by 18 major pharmaceutical companies between 2006 and 2022 found an average success rate of about 14%, meaning roughly 86 out of every 100 drugs that enter human testing never reach the pharmacy shelf. Individual company rates ranged from 8% to 23%.
Placebos and Control Groups
To know whether a treatment truly works, researchers need a comparison point. In some trials, one group receives the experimental treatment while a control group receives a placebo, an inactive substance like a sugar pill. This design helps separate the treatment’s real effects from the natural course of the disease or the psychological boost that comes from believing you’re being treated.
Placebos aren’t always appropriate. When an effective treatment already exists for a condition, it’s generally considered unethical to give some participants nothing. In those cases, researchers use an “active control” design, comparing the new treatment against the current standard of care. This way, no participant goes without a proven option. The tension between these two approaches is an ongoing conversation in research ethics: placebo-controlled trials produce cleaner scientific results, but active-control trials better protect participants.
Ethical Protections for Participants
Clinical research involving people is governed by three foundational ethical principles, laid out in the Belmont Report, a landmark document published by the U.S. Department of Health and Human Services.
The first is respect for persons. Every participant must enter a study voluntarily and with adequate information about what they’re agreeing to. People who have limited ability to make decisions for themselves, such as children or individuals with cognitive impairments, are entitled to additional protections.
The second is beneficence, the obligation to maximize potential benefits while minimizing possible harm. This applies to individual researchers designing a study and to society at large when weighing the value of a research program.
The third is justice, which addresses who bears the risks and who reaps the rewards. Historically, vulnerable populations like prisoners, low-income patients, and racial minorities were disproportionately recruited for risky studies while the benefits of the resulting treatments flowed mainly to more privileged groups. The justice principle demands that participant selection be based on the scientific question, not on convenience or the vulnerability of a population.
What Informed Consent Actually Covers
Before joining any clinical study, you go through an informed consent process. This isn’t just signing a form. Federal regulations require that researchers explain a specific set of details in language you can understand.
You must be told that the study involves research, what its purpose is, how long your participation will last, and exactly what procedures you’ll undergo, including which ones are experimental. The consent must describe foreseeable risks, potential benefits (both to you and to others), and any alternative treatments available outside the study. You’ll learn what happens with your personal data, whether you’ll be compensated, and what treatment is available if you’re injured during the study.
Critically, consent documents must state that participation is entirely voluntary. You have the right to refuse to join and the right to withdraw at any time, for any reason, without penalty. If significant new information emerges during the study that might change your willingness to participate, the research team is required to share it with you.
Diversity in Clinical Trials
A persistent problem in clinical research is that study populations often don’t reflect the people who will ultimately use the treatment. Diseases affect different racial, ethnic, and age groups differently, and a drug tested mostly in one demographic may not work the same way in others. Recognizing this gap, Congress passed legislation requiring sponsors of certain clinical trials to submit diversity action plans to the FDA. These plans outline how the company intends to enroll participants from underrepresented populations. The FDA issued draft guidance in June 2024 detailing the format, content, and submission process for these plans.
How to Find a Clinical Trial
If you’re interested in joining a study, ClinicalTrials.gov is the most comprehensive public database. You can search by condition or disease, by a specific treatment or intervention, or by location. If you’re looking to participate rather than just browse, change the study status filter to “Recruiting or not yet recruiting studies” to see only trials actively seeking volunteers.
You can narrow results further with filters for age group, study phase, and other criteria. Each listing includes the study’s purpose, eligibility requirements, locations, and contact information. Before enrolling in anything, you’ll go through the full informed consent process described above, giving you the chance to ask questions and decide whether the study is right for you.